Project Grant R01NS144457
- Federal Project Grant Award Summary The University of Pennsylvania received a $231,325 Project Grant awarded July 10, 2025, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a five-year research initiative (through June 30, 2030) investigating the neurophysiologic signatures of essential tremor and the mechanisms by which deep brain stimulation...
- Federal Project Grant Award Summary Pennsylvania State University, operating through Penn State Milton S. Hershey Medical Center, received a $432,802 project grant awarded June 1, 2025, from the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The two-year award, with completion scheduled for May 31, 2027, supports cross-validation research of gene expression changes associated...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Pennsylvania a Project Grant totaling $2,817,215 on August 7, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The four-year award, scheduled for completion by July 31, 2029, funds research to elucidate the role of TRIM10 protein in maintaining TDP-43 (TAR DNA-binding protein 43) solubility and...
- Federal Project Grant Award Summary Baylor College of Medicine received a $508,533 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective February 11, 2026, with completion targeted for November 30, 2030. The award supports research investigating state-dependent modulation of cerebellar function, specifically examining how variations in...
- Federal Project Grant Award Summary Harvard Medical School received a $1.2 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2033. The award funds an eight-year basic neuroscience research initiative investigating cerebellar circuit organization and function. The research will employ intersectional...
- Federal Grant Award Summary The University of Pennsylvania received a $149,190 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 6, 2026, with completion anticipated by December 31, 2028. The award funds research to elucidate the mechanistic role of inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) in synaptic transmission...
- Federal Project Grant Award Summary Temple University received a $237,750 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on April 8, 2026, with completion targeted for March 31, 2028. The award supports the development and application of a novel genetic method to selectively lesion axons or prune axonal terminals in the corticospinal...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $637,820 to the Research Institute at Nationwide Children's Hospital on June 11, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project grant supports forward genetic analysis research designed to identify novel genes influencing forebrain neurodevelopment, with specific emphasis on cortical structure, lamination, and...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of The University of Pennsylvania a Project Grant totaling $2,709,695 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award, effective September 5, 2025, with completion targeted for August 31, 2029, funds research investigating the role of TRIM11 (Tripartite Motif 11) protein in regulating transactive...
- Federal Grant Award Summary The University of Pennsylvania received a $646,295 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded June 15, 2026, with completion targeted for May 31, 2031. The grant funds research to develop quantitative methods for assessing seizure network characteristics in patients with drug-resistant epilepsy, addressing...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $585,999 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, effective June 1, 2026, through April 30, 2031, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). This research grant supports investigation into the principles underlying cerebellothalamocortical communication—the pathway connecting the cerebellum to the thalamus and cortex that mediates numerous brain functions ranging from movement to social motivation. The funded research will employ in vitro and in vivo experimental methods, including dynamic clamp electrophysiology, whole-cell recordings, multisite single-unit recordings, CRISPR-mediated genetic manipulation, and pharmacological interventions to elucidate how thalamic burst and tonic firing modes regulate cerebellar inputs to the brain. The research deliverables will advance understanding of how the thalamus controls cerebellar communication under both normal and pathophysiological conditions, with particular emphasis on tremor, a cerebellar dysfunction with established neurobiological origins in the cerebellothalamocortical pathway. By characterizing the dynamic regulation of this critical neural circuit, the project aims to generate mechanistic insights and identify therapeutic targets that could inform strategies to normalize pathological activity and alleviate cerebellar dysfunction, contributing to the NINDS mission of reducing the burden of neurological disease.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $586.0k | 5/25/26 |